Paper
0
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Authors
Michael Wang,Hun Lee
Hubert Chuang,Nicolaus Wagner‐Bartak,Frederick Hagemeister,Jason Westin,Luis Fayad,Felipe Samaniego,Francesco Turturro,Yasuhiro Oki,Wendy Chen,Maria Badillo,Krystle Nomie,Maria Rosa,Donglu Zhao,Laura Lam,Alicia Addison,Hui Zhang,Ken Young,Shaoying Li,David Santos,L. Medeiros,Richard Champlin,Jorge Romaguera
+22 authors
,Leo ZhangJournal
Published
Nov 28, 2015
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.